Industri

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

According to a regulatory filing, Sun Pharma will buy the entire issued and outs...

Japan approves Sanofi’s Sarclisa combo for MM treatment

The approval follows a positive finding in the pivotal IRAKLIA Phase III study, ...

Sun Pharma included in 2026 S&P Dow Jones Best-in-Class...

Inclusion based on S&P Global sustainability assessment covering global companie...

Aurobindo Pharma USA receives FTC approval for Lannett ...

Acquisition to expand Aurobindo USA's portfolio of complex generics and U.S. man...

International Day of Yoga 2026: Nurturing Health, Balan...

Embracing Wellness Beyond Healthcare Every year on June 21, the world comes toge...

Six business lessons from Cipla’s nine-decade journey

Author Vijay Martis explains how Cipla's business model, strategy and purpose s...

Biogen to acquire RayThera for up to $1bn

The deal value comprises an upfront payment and further payments tied to the ach...

Voro and Alloy partner on tumour-selective TCE therapeu...

The partnership will bring together Voro Therapeutics’ tumour-activated biologic...

DIA Medical Writing & Scientific Communications Confere...

Two-day conference to focus on regulatory writing, AI governance, patient-centri...

U.S. Department of Health and Human Services Announces ...

The U.S. Department of Health and Human Services has posted more than $700 milli...

LG AI Research and D&D Pharmatech sign agreement for or...

Executives from both organisations, including LG AI Research head Woohyung Lim a...

Jazz and AbCellera sign deal for T-cell engagers in sol...

The collaboration involves up to $56m in upfront payments to AbCellera for the f...

USFDA and EUDRA dashboards offer lessons for strengthen...

Milind Sathe analyses how public regulatory dashboards can support pharmaceutic...

We’re building for global markets, not just domestic scale

As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is...

Lupin launches Azilsartan Medoxomil tablets in the Unit...

Company receives US FDA approval and secures 180-day generic drug exclusivity fo...

Altaris to acquire Simulations Plus in $375m all-cash deal

Under the deal, Simulations Plus shareholders will receive $18.50 per share, rep...